Albumin-Bilirubin grade predicts prognosis of HCC patients with sorafenib use

Long-term impact of liver function on curative therapy for hepatocellular carcinoma: application of the ALBI grade

(2016) Hidenori Toyoda et al.   BRITISH JOURNAL OF CANCER

Application of the albumin-bilirubin grade for predicting prognosis after curative resection of patients with early-stage hepatocellular carcinoma

(2016) Xiao-Lu Ma et al.   CLINICA CHIMICA ACTA

Evidence-Based Diagnosis, Staging, and Treatment of Patients With Hepatocellular Carcinoma

(2016) Jordi Bruix et al.   GASTROENTEROLOGY

Usefulness of albumin-bilirubin grade for evaluation of prognosis of 2584 Japanese patients with hepatocellular carcinoma

(2016) Atsushi Hiraoka et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Predictors of survival in patients with advanced hepatocellular carcinoma who permanently discontinued sorafenib

(2015) Massimo Iavarone et al.   HEPATOLOGY

Liver function assessment according to the Albumin–Bilirubin (ALBI) grade in sorafenib-treated patients with advanced hepatocellular carcinoma

(2015) Sadahisa Ogasawara et al.   INVESTIGATIONAL NEW DRUGS

Assessment of Liver Function in Patients With Hepatocellular Carcinoma: A New Evidence-Based Approach—The ALBI Grade

(2015) Philip J. Johnson et al.   JOURNAL OF CLINICAL ONCOLOGY

Determinants of Survival After Sorafenib Failure in Patients With BCLC-C Hepatocellular Carcinoma in Real-World Practice

(2015) I-Cheng Lee et al.   MEDICINE

Current management of hepatocellular carcinoma: An Eastern perspective

(2015) Hyung Joon Yim   WORLD JOURNAL OF GASTROENTEROLOGY

EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma

(2015) et al.   JOURNAL OF HEPATOLOGY

Sorafenib Therapy for BCLC Stage B/C Hepatocellular Carcinoma; Clinical Outcome and Safety in Aged Patients: A Multicenter Study in Japan

(2014) Hiroki Nishikawa et al.   Journal of Cancer

A Systematic Review of Sorafenib in Child-Pugh A Patients With Unresectable Hepatocellular Carcinoma

(2013) Ai Shen et al.   JOURNAL OF CLINICAL GASTROENTEROLOGY

Epidemiology of Viral Hepatitis and Hepatocellular Carcinoma

(2012) Hashem B. El-Serag   GASTROENTEROLOGY

Hepatocellular carcinoma

(2012) Alejandro Forner et al.   LANCET

Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010

(2012) Rafael Lozano et al.   LANCET

Field-practice study of sorafenib therapy for hepatocellular carcinoma: A prospective multicenter study in Italy

(2011) Massimo Iavarone et al.   HEPATOLOGY

Management of hepatocellular carcinoma: An update

(2011) Jordi Bruix et al.   HEPATOLOGY

Hepatocellular carcinoma surveillance and appropriate treatment options improve survival for patients with liver cirrhosis

(2010) Yuan-Hung Kuo et al.   EUROPEAN JOURNAL OF CANCER

Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma

(2010) Masao Omata et al.   Hepatology International

Modified RECIST (mRECIST) Assessment for Hepatocellular Carcinoma

(2010) Riccardo Lencioni et al.   SEMINARS IN LIVER DISEASE

Sorafenib for the Treatment of Unresectable Hepatocellular Carcinoma

(2009) R. C. Kane et al.   ONCOLOGIST

Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial

(2008) Ann-Lii Cheng et al.   LANCET ONCOLOGY

Sorafenib in Advanced Hepatocellular Carcinoma

(2008) Josep M. Llovet et al.   NEW ENGLAND JOURNAL OF MEDICINE